Pertussis Vaccine Market Report

Global Pertussis Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：159
  • REPORT CODE：GMM853879
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Pertussis Vaccine market report explains the definition, types, applications, major countries, and major players of the Pertussis Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Sanofi Pasteur

    • GSK

    • Biological Products

    • Chengdu Institute of

    • Beijing Tiantan

    • Wuhan Institute of

    • Changchun Changsheng

    • Astellas Pharma

    • Life Sciences

    • Mitsubishi Tanabe Pharma

    • Minhai Biotechnology

    By Type:

    • Whole-cell Vaccines

    • Acellular Vaccines

    • Other

    By End-User:

    • Children

    • Adults

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Pertussis Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Pertussis Vaccine Outlook to 2028- Original Forecasts

    • 2.2 Pertussis Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Pertussis Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Pertussis Vaccine Market- Recent Developments

    • 6.1 Pertussis Vaccine Market News and Developments

    • 6.2 Pertussis Vaccine Market Deals Landscape

    7 Pertussis Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 Pertussis Vaccine Key Raw Materials

    • 7.2 Pertussis Vaccine Price Trend of Key Raw Materials

    • 7.3 Pertussis Vaccine Key Suppliers of Raw Materials

    • 7.4 Pertussis Vaccine Market Concentration Rate of Raw Materials

    • 7.5 Pertussis Vaccine Cost Structure Analysis

      • 7.5.1 Pertussis Vaccine Raw Materials Analysis

      • 7.5.2 Pertussis Vaccine Labor Cost Analysis

      • 7.5.3 Pertussis Vaccine Manufacturing Expenses Analysis

    8 Global Pertussis Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Pertussis Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Pertussis Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Pertussis Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Pertussis Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Whole-cell Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Acellular Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pertussis Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Children Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Adults Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Pertussis Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global Pertussis Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Pertussis Vaccine Consumption (2017-2022)

      • 10.2.2 Canada Pertussis Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico Pertussis Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Pertussis Vaccine Consumption (2017-2022)

      • 10.3.2 UK Pertussis Vaccine Consumption (2017-2022)

      • 10.3.3 Spain Pertussis Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium Pertussis Vaccine Consumption (2017-2022)

      • 10.3.5 France Pertussis Vaccine Consumption (2017-2022)

      • 10.3.6 Italy Pertussis Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark Pertussis Vaccine Consumption (2017-2022)

      • 10.3.8 Finland Pertussis Vaccine Consumption (2017-2022)

      • 10.3.9 Norway Pertussis Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden Pertussis Vaccine Consumption (2017-2022)

      • 10.3.11 Poland Pertussis Vaccine Consumption (2017-2022)

      • 10.3.12 Russia Pertussis Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey Pertussis Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Pertussis Vaccine Consumption (2017-2022)

      • 10.4.2 Japan Pertussis Vaccine Consumption (2017-2022)

      • 10.4.3 India Pertussis Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea Pertussis Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan Pertussis Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh Pertussis Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia Pertussis Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand Pertussis Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore Pertussis Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia Pertussis Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines Pertussis Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam Pertussis Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Pertussis Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia Pertussis Vaccine Consumption (2017-2022)

      • 10.5.3 Chile Pertussis Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina Pertussis Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela Pertussis Vaccine Consumption (2017-2022)

      • 10.5.6 Peru Pertussis Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Pertussis Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador Pertussis Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Pertussis Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait Pertussis Vaccine Consumption (2017-2022)

      • 10.6.3 Oman Pertussis Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar Pertussis Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Pertussis Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Pertussis Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Pertussis Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa Pertussis Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt Pertussis Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria Pertussis Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Pertussis Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand Pertussis Vaccine Consumption (2017-2022)

    11 Global Pertussis Vaccine Competitive Analysis

    • 11.1 Sanofi Pasteur

      • 11.1.1 Sanofi Pasteur Company Details

      • 11.1.2 Sanofi Pasteur Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Sanofi Pasteur Pertussis Vaccine Main Business and Markets Served

      • 11.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 GSK

      • 11.2.1 GSK Company Details

      • 11.2.2 GSK Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 GSK Pertussis Vaccine Main Business and Markets Served

      • 11.2.4 GSK Pertussis Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Biological Products

      • 11.3.1 Biological Products Company Details

      • 11.3.2 Biological Products Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Biological Products Pertussis Vaccine Main Business and Markets Served

      • 11.3.4 Biological Products Pertussis Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Chengdu Institute of

      • 11.4.1 Chengdu Institute of Company Details

      • 11.4.2 Chengdu Institute of Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Chengdu Institute of Pertussis Vaccine Main Business and Markets Served

      • 11.4.4 Chengdu Institute of Pertussis Vaccine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Beijing Tiantan

      • 11.5.1 Beijing Tiantan Company Details

      • 11.5.2 Beijing Tiantan Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Beijing Tiantan Pertussis Vaccine Main Business and Markets Served

      • 11.5.4 Beijing Tiantan Pertussis Vaccine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Wuhan Institute of

      • 11.6.1 Wuhan Institute of Company Details

      • 11.6.2 Wuhan Institute of Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Wuhan Institute of Pertussis Vaccine Main Business and Markets Served

      • 11.6.4 Wuhan Institute of Pertussis Vaccine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Changchun Changsheng

      • 11.7.1 Changchun Changsheng Company Details

      • 11.7.2 Changchun Changsheng Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Changchun Changsheng Pertussis Vaccine Main Business and Markets Served

      • 11.7.4 Changchun Changsheng Pertussis Vaccine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Astellas Pharma

      • 11.8.1 Astellas Pharma Company Details

      • 11.8.2 Astellas Pharma Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Astellas Pharma Pertussis Vaccine Main Business and Markets Served

      • 11.8.4 Astellas Pharma Pertussis Vaccine Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Life Sciences

      • 11.9.1 Life Sciences Company Details

      • 11.9.2 Life Sciences Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Life Sciences Pertussis Vaccine Main Business and Markets Served

      • 11.9.4 Life Sciences Pertussis Vaccine Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Mitsubishi Tanabe Pharma

      • 11.10.1 Mitsubishi Tanabe Pharma Company Details

      • 11.10.2 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Main Business and Markets Served

      • 11.10.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Minhai Biotechnology

      • 11.11.1 Minhai Biotechnology Company Details

      • 11.11.2 Minhai Biotechnology Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Minhai Biotechnology Pertussis Vaccine Main Business and Markets Served

      • 11.11.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    12 Global Pertussis Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global Pertussis Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Whole-cell Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Acellular Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Pertussis Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Children Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Adults Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Pertussis Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global Pertussis Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Pertussis Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Pertussis Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Pertussis Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Pertussis Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Pertussis Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Pertussis Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Pertussis Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Pertussis Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Pertussis Vaccine

    • Figure of Pertussis Vaccine Picture

    • Table Global Pertussis Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Pertussis Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Whole-cell Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Acellular Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Children Consumption and Growth Rate (2017-2022)

    • Figure Global Adults Consumption and Growth Rate (2017-2022)

    • Figure Global Pertussis Vaccine Consumption by Country (2017-2022)

    • Table North America Pertussis Vaccine Consumption by Country (2017-2022)

    • Figure United States Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Pertussis Vaccine Consumption by Country (2017-2022)

    • Figure Germany Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC Pertussis Vaccine Consumption by Country (2017-2022)

    • Figure China Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America Pertussis Vaccine Consumption by Country (2017-2022)

    • Figure Brazil Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC Pertussis Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa Pertussis Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania Pertussis Vaccine Consumption by Country (2017-2022)

    • Figure Australia Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Table Sanofi Pasteur Company Details

    • Table Sanofi Pasteur Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur Pertussis Vaccine Main Business and Markets Served

    • Table Sanofi Pasteur Pertussis Vaccine Product Portfolio

    • Table GSK Company Details

    • Table GSK Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Pertussis Vaccine Main Business and Markets Served

    • Table GSK Pertussis Vaccine Product Portfolio

    • Table Biological Products Company Details

    • Table Biological Products Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biological Products Pertussis Vaccine Main Business and Markets Served

    • Table Biological Products Pertussis Vaccine Product Portfolio

    • Table Chengdu Institute of Company Details

    • Table Chengdu Institute of Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chengdu Institute of Pertussis Vaccine Main Business and Markets Served

    • Table Chengdu Institute of Pertussis Vaccine Product Portfolio

    • Table Beijing Tiantan Company Details

    • Table Beijing Tiantan Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beijing Tiantan Pertussis Vaccine Main Business and Markets Served

    • Table Beijing Tiantan Pertussis Vaccine Product Portfolio

    • Table Wuhan Institute of Company Details

    • Table Wuhan Institute of Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Wuhan Institute of Pertussis Vaccine Main Business and Markets Served

    • Table Wuhan Institute of Pertussis Vaccine Product Portfolio

    • Table Changchun Changsheng Company Details

    • Table Changchun Changsheng Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Changchun Changsheng Pertussis Vaccine Main Business and Markets Served

    • Table Changchun Changsheng Pertussis Vaccine Product Portfolio

    • Table Astellas Pharma Company Details

    • Table Astellas Pharma Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Pertussis Vaccine Main Business and Markets Served

    • Table Astellas Pharma Pertussis Vaccine Product Portfolio

    • Table Life Sciences Company Details

    • Table Life Sciences Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Life Sciences Pertussis Vaccine Main Business and Markets Served

    • Table Life Sciences Pertussis Vaccine Product Portfolio

    • Table Mitsubishi Tanabe Pharma Company Details

    • Table Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mitsubishi Tanabe Pharma Pertussis Vaccine Main Business and Markets Served

    • Table Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio

    • Table Minhai Biotechnology Company Details

    • Table Minhai Biotechnology Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Minhai Biotechnology Pertussis Vaccine Main Business and Markets Served

    • Table Minhai Biotechnology Pertussis Vaccine Product Portfolio

    • Figure Global Whole-cell Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acellular Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Children Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pertussis Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America Pertussis Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pertussis Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Pertussis Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Pertussis Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Pertussis Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Pertussis Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Pertussis Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US